Medication info
Tenegrin Duo Sustained-Release Tablet 10/750 mg

Tenegrin Duo Sustained-Release Tablet 10/750 mg

Prescription medicationTabletOral
Ingredient · strength
Teneligliptin Hydrochloride Hydrate›13mg / 1 tabletMetformin Hydrochloride›750mg / 1 tablet
Manufacturer / importer
Jinyang Pharmaceutical Co., Ltd.
Appearance
Yellow egg-shaped sustained-release film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202201439 · Approved 2022.04.04 · Insurance code 650304300

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The dose of this drug should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This drug is generally administered once daily with the evening meal, and the dose should be increased gradually to reduce gastrointestinal adverse reactions associated with metformin. Take 1 tablet of this drug 20/1000mg extended-release tablets once daily. Patients taking this drug 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. For patients whose blood glucose is not adequately controlled with metformin monotherapy, the initial dose of this drug should provide teneligliptin 20 mg once daily and the patient's current metformin dose. For patients switching from combination therapy with teneligliptin and metformin to this drug, treatment may be initiated at the patient's current doses of teneligliptin and metformin. When switching from immediate-release to extended-release metformin, blood glucose control should be closely monitored and the dose adjusted appropriately. When coadministered with a sulfonylurea, reducing the dose of the sulfonylurea may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this drug have not been specifically evaluated in patients switched to this drug from another antihyperglycemic agent. Because changes may affect blood glucose control, any changes in the treatment of patients with type 2 diabetes mellitus should be made under careful monitoring. To maintain the extended-release properties, this drug should be swallowed whole and not split, crushed, ground, or chewed.

Ingredients

Manufacturer
Jinyang Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

View approved original text

This medication is used to assist meal therapy and exercise therapy to improve blood sugar control in patients with type 2 diabetes. The combined administration of teneligliptin and metformin enhances blood sugar control effects, aiding in diabetes management. Taking this medication consistently contributes to maintaining stable blood sugar levels.

How to take

Adult dose

The dose of this drug should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This drug is generally administered once daily with the evening meal, and the dose should be increased gradually to reduce gastrointestinal adverse reactions associated with metformin. Take 1 tablet of this drug 20/1000mg extended-release tablets once daily. Patients taking this drug 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. For patients whose blood glucose is not adequately controlled with metformin monotherapy, the initial dose of this drug should provide teneligliptin 20 mg once daily and the patient's current metformin dose. For patients switching from combination therapy with teneligliptin and metformin to this drug, treatment may be initiated at the patient's current doses of teneligliptin and metformin. When switching from immediate-release to extended-release metformin, blood glucose control should be closely monitored and the dose adjusted appropriately. When coadministered with a sulfonylurea, reducing the dose of the sulfonylurea may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this drug have not been specifically evaluated in patients switched to this drug from another antihyperglycemic agent. Because changes may affect blood glucose control, any changes in the treatment of patients with type 2 diabetes mellitus should be made under careful monitoring. To maintain the extended-release properties, this drug should be swallowed whole and not split, crushed, ground, or chewed.

Precautions

This medication helps regulate blood sugar levels. However, there are several precautions to consider when taking it. First, though rare, a severe condition called lactic acidosis may occur. Lactic acidosis is a dangerous condition that arises from excessive buildup of lactic acid in the body and can be life-threatening; symptoms should be reported to a physician immediately. Additionally, hypoglycemia may occur when taken in conjunction with other diabetes medications, so blood sugar levels need to be monitored carefully. Patients with moderate to severe renal impairment or those with heart failure or liver dysfunction should not take this medication. Furthermore, it is advisable to discontinue this medication for a certain period before and after any examination involving the use of radiological contrast agents. Women who are pregnant or may become pregnant should not take this medication, and it is also not recommended for nursing mothers. This medication may occasionally cause side effects such as indigestion, diarrhea, constipation, dizziness, fatigue, facial swelling, nausea, itching, cold sweat, allergic dermatitis, malaise, elevated serum uric acid, peripheral edema, upper respiratory tract infection, shingles, viral upper respiratory infection, fatigue, nasopharyngitis, vomiting, gastritis, chronic gastritis, upper abdominal pain, stomatitis, gastrointestinal motility disorders, reduced gastrointestinal motility, enteritis, tooth pain, and anal discomfort. Regular kidney function and blood tests should be performed during treatment, and periodic checks for low vitamin B12 levels are necessary. Moreover, it is safest to stop this medication if consuming alcohol excessively, in a dehydrated state, during severe infections, or before and after surgery. Caution should also be taken when driving or performing high-altitude work due to the risk of hypoglycemia or lactic acidosis. Finally, other medications taken concurrently may interact with this drug, so any current medications should be disclosed to a physician or pharmacist.

Side effects

  • Severe lactic acidosis
  • severe hypoglycemia
  • hypoglycemia
  • constipation
  • intestinal obstruction
  • liver dysfunction
  • interstitial pneumonia
  • pemphigus
  • acute pancreatitis
  • dizziness
Show 179 more
  • abdominal distension
  • abdominal discomfort
  • nausea
  • abdominal pain
  • bloating
  • stomatitis
  • gastric polyps
  • colon polyps
  • duodenal ulcers
  • gastroesophageal reflux disease
  • diarrhea
  • loss of appetite
  • increased amylase
  • increased lipase
  • increased AST (GOT)
  • increased ALT (GPT)
  • increased GGT
  • increased ALP
  • proteinuria
  • ketonuria
  • latent hematuria
  • eczema
  • rash
  • itching
  • allergic dermatitis
  • arthralgia
  • increased CK (CPK)
  • elevated serum potassium concentration
  • malaise
  • allergic rhinitis
  • elevated serum uric acid
  • peripheral edema
  • herpes zoster
  • limb pain
  • epigastric pain
  • gastritis
  • upper respiratory infection
  • tremor
  • headache
  • muscular weakness
  • hunger
  • fatigue
  • facial edema
  • dyspepsia
  • nausea
  • viral upper respiratory infection
  • rhinitis
  • diaphoresis
  • diabetic retinopathy
  • vision loss
  • cough
  • pulmonary congestion
  • dyspnea
  • drug overdose
  • benign prostatic hyperplasia
  • headache
  • diarrhea
  • chronic gastritis
  • irritable bowel syndrome
  • fatigue
  • cerebral infarction
  • hyperglycemia
  • liver biopsy
  • neutrophil count decrease
  • abnormal blood sugar
  • increased blood sugar
  • increased blood pressure
  • hepatic coma
  • lumbar spinal canal stenosis
  • intervertebral disc protrusion
  • intervertebral disc disorder
  • spinal ligament ossification
  • foraminal stenosis
  • rotator cuff syndrome
  • bladder tumor
  • ureteral stone disease
  • urinary calculi
  • coronary artery disease
  • unstable angina
  • gastroesophageal reflux disease
  • gastric polyps
  • gastritis
  • biliary obstruction
  • chronic cholecystitis
  • soft tissue infection
  • pneumonia
  • cataract
  • depression
  • iliac artery stenosis
  • dizziness
  • benign prostatic hyperplasia
  • knee surgery
  • dizziness
  • diabetic neuropathy
  • sensory disturbances
  • urticaria
  • hepatic coma
  • sensory loss
  • tension headache
  • peripheral neuropathy
  • facial paralysis
  • sciatica
  • orthostatic dizziness
  • muscle weakness
  • back pain
  • limb pain
  • lumbar spinal canal stenosis
  • tendonitis
  • cervical pain
  • bone pain
  • osteoarthritis
  • osteoporosis
  • muscle cramps
  • foot deformities
  • hypertrophic osteoarthritis
  • bursitis
  • spinal osteoarthritis
  • intervertebral disc protrusion
  • intervertebral disc disorder
  • spinal ligament ossification
  • foraminal stenosis
  • postmenopausal osteoporosis
  • rotator cuff syndrome
  • herpes zoster
  • upper respiratory infection
  • gastroenteritis
  • chronic sinusitis
  • folliculitis
  • cystitis
  • urinary tract infection
  • pharyngitis
  • streptococcal infection
  • tinea pedis
  • subcutaneous abscess
  • Helicobacter gastritis
  • vomiting
  • chronic gastritis
  • epigastric pain
  • dysentery
  • esophagitis
  • gastrointestinal motility disorders
  • gastrointestinal motility reduction
  • enteritis
  • toothache
  • anal rectal discomfort
  • acquired mixed hyperlipidemia
  • hypertriglyceridemia
  • vitamin D deficiency
  • abnormal weight gain
  • essential hypertension
  • orthostatic hypotension
  • white coat hypertension
  • hemorrhage
  • increased blood sugar
  • abnormal sputum
  • increased serum creatinine
  • increased blood urea
  • anemia
  • food allergy
  • pressure ulcer
  • glaucoma
  • blurred vision
  • age-related macular degeneration
  • hyperthyroidism
  • hyperparathyroidism
  • coronary artery disease
  • angina
  • ear pain
  • iron deficiency anemia
  • food allergy
  • hearing loss
  • endolymphatic hydrops
  • benign prostatic hyperplasia
  • urticaria
  • cataract
  • dizziness
  • depression
  • insomnia
  • decreased serum vitamin B12

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air ingress and kept at room temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the medication's efficacy for a longer time.

Appearance and packaging

Appearance

Yellow egg-shaped sustained-release film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.